Karen Long, managing director at KCK Group
In this week’s DeviceTalks Weekly Podcast, Karen Long, managing director at KCK Group, says startups looking for funding have an opportunity to catch the eye and ear of investors.
KCK, an active medtech investor, has been involved in two sizable investments this summer including Aerin Medical and NeuroPace. Both were portfolio companies, but Long says KCK is in the market for new deals.
“We’re looking at companies and where we have the ability to take these ZOOM calls and take pitches that would have normally required a lot of travel and a lot of time to plan,” Long said in this week’s episode.” We can do it in a half hour, 45 minutes and at least we have the introduction and can see if it makes sense to continue.”
Medtech executives looking for more insight on the fundraising market can register for today’s DeviceTalks Tuesday discussion where Long and Isaac Ro, CFO, of Thrive Earlier Detection, will discussing “Raising Capital in the Zoom Age.” Thrive closed on a $257 million Series B in August.
Go here to register.
Gail Daubert, founding partner at 4Front Strategies walks us through the proposed CMS rule to pay for innovative breakthrough technologies. Daubert suggests industry leaders offer their feedback on the proposed rule here.
Chris Newmarker, executive editor of life sciences at MassDevice, reports on the five biggest Medtech newsmakers. Items involve Medtronic, IBM, Elon Musk, and CMS.